JADPRO Live

Looking to deepen your knowledge in multiple myeloma management? Discover tools, clinical updates, and expert perspectives designed to support advanced practitioners in delivering high-quality, patient-centered care. Visit the Multiple Myeloma Resource Center: https://lnkd.in/euSRbNam

Advanced practitioners, share your work with your peers by submitting an abstract to #JADPROLive! Present innovative, original work that is significant to the role of the advanced practitioner in oncology and hematology. The deadline to submit is July 1. Learn more about the poster tracks and access full guidelines: https://bit.ly/3OFOlbQ

What’s next for MGUS? Ongoing research focuses on refining monitoring guidelines, identifying high-risk patients earlier, and developing preventive strategies to reduce progression to malignancy. Learn more: https://bit.ly/4maAaZ3 #OncologyResearch #MultipleMyeloma #FutureOfCare

CAR T-cell therapy is transforming outcomes in hematologic malignancies, and advanced practitioners play a critical role in care delivery. Access curated resources, real-world case insights, and expert guidance to support your clinical decision-making. Visit the CAR T-Cell Therapy Resource Center: https://lnkd.in/empV9k8q

🎉 JADPRO Live registration is officially OPEN! Join us October 15–18 in Minneapolis for the premier CE-accredited conference, bringing together a community of advanced practitioners dedicated to advancing cancer care. Earn CE credits, connect with your peers, and bring back actionable insights to elevate your practice. Register today: https://lnkd.in/diNSebP

Stay ahead of the latest in oncology with FDA Focus Access the newest FDA oncology approvals and expanded indications, paired with expert pharmacist insights to help you make confident clinical decisions. Explore FDA Focus: https://lnkd.in/eDaCKjCF

How do you approach first-line treatment in high-risk CLL? In this case-based discussion, Amy Goodrich, RN, BSN, MSN, CRNP-AC of Sidney Kimmel Comprehensive Cancer Center at Jefferson, Jill Miller, MS, PA-C of The University of Texas MD Anderson Cancer Center, and mollie moran, APRN-CNP of Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute, review management strategies for a patient with TP53 mutation and del(17p), highlighting the role of BTK inhibitor monotherapy in maintaining efficacy while supporting patient lifestyle preferences. Watch the roundtable: https://bit.ly/41yVgGW 

Advanced practitioners play a critical role in breast cancer care. The HR+ HER2– Breast Cancer Resource Center provides current research, practice advancements, and clinical tools to support evidence-based oncology care. Visit the Resource Center: https://lnkd.in/eDH8srPQ

Managing chronic immune thrombocytopenia (ITP) goes beyond platelet counts. A recent learning exchange highlights key priorities from patients, caregivers, and clinicians including self-advocacy, shared decision-making, and better support resources. Read the full article: https://bit.ly/4bLUw5X #Hematology #PatientCenteredCare #ITP #AdvancedPractice

Management of follicular lymphoma continues to evolve. In this JADPRO Roundtable, Kim Grazier, DNP, AGPCNP-BC of Atrium Health, Allison Karabinos, PharmD, BCOP of Atrium Health, and Susan Woodward, MSN, APRN, AOCNP® of Moffitt Cancer Center,  discuss the diagnosis, staging, and evolving management of follicular lymphoma. This stage IV case highlights the importance of accurate staging, grading, and risk assessment, along with evaluating options like rituximab, chemoimmunotherapy, and clinical trial enrollment. Watch here: https://bit.ly/4vxZHQ3